Login
Business
Entertainment
World
Health
Environment
Lifestyle
National
Science
Sports
World
Movies
Web Series
Technology
Cricket
Coronavirus
Auto
Ajab Ghazab
Finance
India
International
Religious
Politics
Home Articles Bharat Biotech
DCGI approves ‘5-arms intranasal hetrologous booster dose’ for restricted use \
4 min read
\
\

DCGI approves ‘5-arms intranasal hetrologous booster dose’ for restricted use

 25-Nov-2022
The Drugs Controller General of India (DCGI) has given approval to intranasal "Five Arms" booster dose for restricted use for COVID-19 patients, it is learnt.
25-Nov-2022 National
\
Bharat Biotech applies for market authorisation from DCGI for five arms intranasal heterologous booster \
5 min read
\
\

Bharat Biotech applies for market authorisation from DCGI for five arms intranasal heterologous booster

 11-Sep-2022
New Delhi [India], September 11 (ANI): Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous booster, sources told ANI.
11-Sep-2022 National
\
Bharat Biotech-made iNCOVACC becomes world’s first intranasal COVID vaccine to get EUA \
4 min read
\
\

Bharat Biotech-made iNCOVACC becomes world’s first intranasal COVID vaccine to get EUA

 06-Sep-2022
New Delhi [India], September 6 (ANI): The Drugs Controller General of India (DCGI) rendered an emergency use authorization (EUA) to Bharat Biotech for the intranasal vaccine- iNCOVACC, said officials on Tuesday.
06-Sep-2022 National
\
Bharat Biotech completes clinical development for phase III trials, booster doses for BBV154 intranasal Covid vaccine \
4 min read
\
\

Bharat Biotech completes clinical development for phase III trials, booster doses for BBV154 intranasal Covid vaccine

 15-Aug-2022
Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal vaccine) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
15-Aug-2022 National
\
Japan approves COVAXIN booster dose for travellers: Bharat Biotech \
3 min read
\
\

Japan approves COVAXIN booster dose for travellers: Bharat Biotech

 05-Aug-2022
Hyderabad [Telangana], August 5 (ANI): Hyderabad-based Bharat Biotech on Friday announced that Japan has approved the COVAXIN booster dose for travellers.
05-Aug-2022 World
\
Covaxin booster dose increases immune response by 40 times, gives long-term immunity against COVID-19: Bharat Biotech \
3 min read
\
\

Covaxin booster dose increases immune response by 40 times, gives long-term immunity against COVID-19: Bharat Biotech

 20-Jul-2022
Hyderabad (Telangana) [India], July 20 (ANI): Hyderabad-based Bharat Biotech on Wednesday announced that the administration of the third dose of its COVID-19 vaccine Covaxin (BBV152) after six months of two-dose vaccination dramatically increased neutralizing antibody responses against both homologous and heterologous strains (Alpha, Beta, Delta, Delta Plus and Omicron) and showed increased memory B cell response in subjects in controlled clinical trials.
20-Jul-2022 National
\
Covaxin safe for children aged 2-18 years, says Bharat Biotech \
3 min read
\
\

Covaxin safe for children aged 2-18 years, says Bharat Biotech

 17-Jun-2022
Hyderabad (Telangana) [India], June 17 (ANI): Bharat Biotech International Limited (BBIL) on Thursday announced that Covaxin, its whole-virion inactivated COVID-19 vaccine has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study, said a press release.
17-Jun-2022 National
\
CEPI partners with Bharat Biotech, University of Sydney, ExcellGene to develop ‘variant-proof’ COVID-19 vaccine \
7 min read
\
\

CEPI partners with Bharat Biotech, University of Sydney, ExcellGene to develop ‘variant-proof’ COVID-19 vaccine

 10-May-2022
Oslo [Norway], May 10 (ANI): The Coalition for Epidemic Preparedness Innovations (CEPI) on Tuesday announced the latest award under its USD 200 m programme to advance the development of vaccines that provide broad protection against SARS-Cov-2 variants and other beta coronaviruses.
10-May-2022 World
\
‘Portrays incorrect picture’, MEA on reports of it asking Bharat Biotech to address COVID vaccine issues \
2 min read
\
\

‘Portrays incorrect picture’, MEA on reports of it asking Bharat Biotech to address COVID vaccine issues

 29-Apr-2022
New Delhi [India], April 29 (ANI): The Minstry of External Affairs has said that media reports purportedly quoting a communication from the ministry asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval (EUA) nod for its COVID jab, "potrayed an incorrect picture."
29-Apr-2022 World
\
DCGI approves COVID-19 vaccine Covaxin for children aged 6-12 \
4 min read
\
\

DCGI approves COVID-19 vaccine Covaxin for children aged 6-12

 26-Apr-2022
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
26-Apr-2022 National
\